Immunotherapy in non-small cell lung cancer: Past, present, and future directions von Punekar, Salman R., Shum, Elaine, Grello, Cassandra Mia, Lau, Sally C., Velcheti, Vamsidhar

Volltext

Nemvaleukin alfa, a novel engineered IL-2 fusion protein, drives antitumor immunity and inhibits tumor growth in small cell lung cancer von Pan, Yuanwang, Hao, Yuan, Han, Han, Chen, Ting, Ding, Hailin, Labbe, Kristen E, Shum, Elaine, Guidry, Kayla, Hu, Hai, Sherman, Fiona, Geng, Ke, Stephens, Janaye, Chafitz, Alison, Tang, Sittinon, Huang, Hsin-Yi, Peng, Chengwei, Almonte, Christina, Lopes, Jared E, Losey, Heather C, Winquist, Raymond J, Velcheti, Vamsidhar, Zhang, Hua, Wong, Kwok-Kin

Volltext

490 Clinical benefit through Siglec-15 targeting with NC318 antibody in subjects with Siglec-15 positive advanced solid tumors von Shum, Elaine, Myint, Han, Shaik, Jahangheer, Zhou, Qinjie, Barbu, Emilia, Morawski, Aaron, Abukharma, Hasan, Liu, Linda, Nelson, Megan, Zeidan, Stephanie, Cusumano, Zachary, Tolcher, Anthony, Langermann, Solomon, Gutierrez, Martin, Hamid, Omid

Volltext

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial von Chaft, Jamie E., Oezkan, Filiz, Kris, Mark G., Bunn, Paul A., Wistuba, Ignacio I., Kwiatkowski, David J., Owen, Dwight H., Tang, Yan, Johnson, Bruce E., Lee, Jay M., Lozanski, Gerard, Pietrzak, Maciej, Seweryn, Michal, Byun, Woo Yul, Schulze, Katja, Nicholas, Alan, Johnson, Ann, Grindheim, Jessica, Hilz, Stephanie, Shames, David S., Rivard, Chris, Toloza, Eric, Haura, Eric B., McNamee, Ciaran J., Patterson, G. Alexander, Waqar, Saiama N., Rusch, Valerie W., Carbone, David P.

Volltext

523 Preliminary clinical experience with XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors von Shum, Elaine, Reilley, Matthew, Najjar, Yana, Daud, Adil, Thompson, John, Baranda, Joaquina, Donald Harvey, R, Shields, Anthony, Cohen, Ezra, Pant, Shubham, Leidner, Rom, Mita, Alain, Cohen, Roger, Chmielowski, Bartosz, Stein, Mark, Hu-Lieskovan, Siwen, Fleener, Catherine, Ding, Ying, Bao, Lei, Chollate, Sowmya, Shorr, Jolene, Clynes, Raphael, Hickingbottom, Barbara

Volltext

407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors von Shum, Elaine, Daud, Adil, Reilley, Matthew, Najjar, Yana, Thompson, John, Baranda, Joaquina, Donald Harvey, R, Leidner, Rom, Shields, Anthony, Cohen, Ezra, Cohen, Roger, Mita, Alain, Pant, Shubham, Stein, Mark, Chmielowski, Bartosz, Hu-Lieskovan, Siwen, Fleener, Catherine, Ding, Ying, Chollate, Sowmya, Avina, Hector, Shorr, Jolene, Clynes, Raphael, Hickingbottom, Barbara

Volltext

Functional Analysis of MET Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination von Wang, Feng, Liu, Yang, Qiu, Wanglong, Shum, Elaine, Feng, Monica, Zhao, Dejian, Zheng, Deyou, Borczuk, Alain, Cheng, Haiying, Halmos, Balazs

Volltext

Expanding the Role of Immunotherapy to Limited-Stage SCLC von Punekar, Salman R., Shum, Elaine

Volltext

Preliminary results from the Female Asian Nonsmoker Screening Study (FANSS) von Shum, Elaine, Li, Wenyuan, Sequist, Lecia V., Ou, Sai-Hong Ignatius, Goldberg, Judith D., Chachoua, Abraham, Wong, Kwok-Kin

Volltext

Molecular cytology of the respiratory tract and pleura von Zhou, Fang, Shum, Elaine, Moreira, Andre L.

Volltext

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial von Chaft, Jamie E., Oezkan, Filiz, Kris, Mark G., Bunn, Paul A., Wistuba, Ignacio I., Kwiatkowski, David J., Owen, Dwight H., Tang, Yan, Johnson, Bruce E., Lee, Jay M., Lozanski, Gerard, Pietrzak, Maciej, Seweryn, Michal, Byun, Woo Yul, Schulze, Katja, Nicholas, Alan, Johnson, Ann, Grindheim, Jessica, Hilz, Stephanie, Shames, David S., Rivard, Chris, Toloza, Eric, Haura, Eric B., McNamee, Ciaran J., Patterson, G. Alexander, Waqar, Saiama N., Rusch, Valerie W., Carbone, David P.

Volltext

Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting Lung Cancer as in Asian Male Ever-Smokers: A Systematic Revie... von Triphuridet, Natthaya, Zhang, Shannon S., Nagasaka, Misako, Gao, Yanfei, Zhao, Joseph J., Syn, Nicholas L., Hanaoka, Takaomi, Ou, Sai-Hong Ignatius, Shum, Elaine

Volltext

Assessing the predictive value of ctDNA on relapse in patients with resected stage IB-IIIA NSCLC treated with adjuvant chemotherapy plus concomitant atezolizumab followed by atezol... von Ardeshir-Larijani, Fatemeh, Mohindra, Nisha Anjali, Traynor, Anne M., Malhotra, Jyoti, Shum, Elaine, Ma, Patrick C., Hanna, Nasser H.

Volltext

Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy von Hellmann, Matthew D., Janne, Pasi A., Opyrchal, Mateusz, Hafez, Navid, Raez, Luis E., Gabrilovich, Dmitry, Wang, Fang, Trepel, Jane B., Lee, Min-Jung, Yuno, Akira, Lee, Sunmin, Brouwer, Susan, Sankoh, Serap, Wang, Lei, Tamang, David, Schmidt, Emmett, Meyers, Michael L., Ramalingam, Suresh S., Shum, Elaine, Ordentlich, Peter

Volltext

Real-world clinical outcomes in a U.S. Asian population with stage IV NSCLC treated with osimertinib (Osi) stratified by EGFR subtype von Liu, Ying, Bi, Jason, Moreira, Andre, Chachoua, Abraham, Velcheti, Vamsidhar, Lau, Sally C. M., Punekar, Salman Rafi, Sabari, Joshua K., Shum, Elaine

Volltext

Finding a place for ceritinib in the landscape of ALK-positive non-small cell lung cancer von Shum, Elaine, Gandhi, Leena

Volltext

Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives von Lee, Jay M., McNamee, Ciaran J., Toloza, Eric, Negrao, Marcelo V., Lin, Jules, Shum, Elaine, Cummings, Amy L., Kris, Mark G., Sepesi, Boris, Bara, Ilze, Kurtsikidze, Nino, Schulze, Katja, Ngiam, Celina, Chaft, Jamie E.

Volltext

Race, age at diagnosis and histological characteristics of lung cancer in never-smokers (LCINS) and ever-smokers in low-dose computed tomography (LDCT) screening: a systematic revi... von Triphuridet, Natthaya, Nagasaka, Misako, Shum, Elaine, Ou, Sai-Hong Ignatius

Volltext

Abstract 2740: MET exon 14 skipping mutation promotes metastasis via activation of the PI3K/Akt-Rac1 pathway in non-small cell lung cancer von Wang, Feng, Shum, Elaine, Perez-Soler, Roman, Cheng, Haiying, Halmos, Balazs

Volltext

The selective personalized radioimmunotherapy for locally advanced NSCLC trial (SPRINT) von Ohri, Nitin, Cheng, Haiying, Jolly, Shruti, Gadgeel, Shirish M., Cooper, Benjamin Thomas, Shum, Elaine, Halmos, Balazs

Volltext